Insider Trades75 trades
| Date↓ | Side | Ticker↕ | Insider↕ | Role↕ | Shares↕ | Price↕ | Mkt Cap↕ | 52W High↕ | 52W Low↕ | Value↕ | % Chg↕ | Rule↕ | AI View↕ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Aug 10, 2026 | Sell | IOVA | Daniel Gordon Kirby | Chief Commercial Officer | 2,436 | $6.40 | $3.9B | -8.12% | +388.64% | $15.6K | -1.12% | — | Stalk |
| Aug 6, 2026 | Sell | IOVA | Corleen M. Roche | Chief Financial Officer | 21,238 | $6.21 | $3.9B | -8.12% | +388.64% | $131.9K | -14.16% | — | Stalk |
| Jun 5, 2026 | Sell | IOVA | Raj K. Puri | Chief Regulatory Officer | 3,843 | $4.23 | $3.9B | -8.12% | +388.64% | $16.3K | -1.20% | — | Stalk |
| Jun 5, 2026 | Sell | IOVA | Igor Bilinsky | Chief Operating Officer | 3,976 | $4.23 | $3.9B | -8.12% | +388.64% | $16.8K | -2.06% | — | Stalk |
| Jun 5, 2026 | Sell | IOVA | Finckenstein Friedrich Graf | Chief Medical Officer | 3,976 | $4.23 | $3.9B | -8.12% | +388.64% | $16.8K | -2.00% | — | Stalk |
| Jun 5, 2026 | Sell | IOVA | Frederick G Vogt | Interim CEO & General Counsel | 6,638 | $4.23 | $3.9B | -8.12% | +388.64% | $28.1K | -0.98% | — | Stalk |
| Jun 1, 2026 | Sell | IOVA | Raj K. Puri | Chief Regulatory Officer | 2,508 | $3.96 | $3.9B | -8.12% | +388.64% | $9.9K | -0.96% | — | Stalk |
| Jun 1, 2026 | Sell | IOVA | Igor Bilinsky | Chief Operating Officer | 4,473 | $3.96 | $3.9B | -8.12% | +388.64% | $17.7K | -2.78% | — | Stalk |
| Jun 1, 2026 | Sell | IOVA | Finckenstein Friedrich Graf | Chief Medical Officer | 4,473 | $3.96 | $3.9B | -8.12% | +388.64% | $17.7K | -2.68% | — | Stalk |
| Jun 1, 2026 | Sell | IOVA | Frederick G Vogt | Interim CEO & General Counsel | 17,701 | $3.96 | $3.9B | -8.12% | +388.64% | $70.1K | -2.54% | — | Stalk |
| May 11, 2026 | Sell | IOVA | Daniel Gordon Kirby | Chief Commercial Officer | 2,435 | $3.70 | $3.9B | -8.12% | +388.64% | $9.0K | -1.11% | — | Stalk |
| Mar 5, 2026 | Sell | IOVA | Finckenstein Friedrich Graf | Chief Medical Officer | 16,520 | $4.58 | $3.9B | -8.12% | +388.64% | $75.7K | -7.83% | — | Stalk |
| Mar 5, 2026 | Sell | IOVA | Igor Bilinsky | Chief Operating Officer | 16,628 | $4.58 | $3.9B | -8.12% | +388.64% | $76.2K | -8.12% | — | Stalk |
| Mar 5, 2026 | Sell | IOVA | Raj K. Puri | Chief Regulatory Officer | 18,360 | $4.58 | $3.9B | -8.12% | +388.64% | $84.1K | -5.47% | — | Stalk |
| Mar 5, 2026 | Sell | IOVA | Frederick G Vogt | Interim CEO & General Counsel | 26,755 | $4.58 | $3.9B | -8.12% | +388.64% | $122.5K | -3.93% | — | Stalk |
| Mar 2, 2026 | Sell | IOVA | Raj K. Puri | Chief Regulatory Officer | 2,798 | $3.79 | $3.9B | -8.12% | +388.64% | $10.6K | -1.15% | — | Stalk |
| Mar 2, 2026 | Sell | IOVA | Igor Bilinsky | Chief Operating Officer | 6,903 | $3.79 | $3.9B | -8.12% | +388.64% | $26.2K | -4.51% | — | Stalk |
| Mar 2, 2026 | Sell | IOVA | Finckenstein Friedrich Graf | Chief Medical Officer | 7,122 | $3.79 | $3.9B | -8.12% | +388.64% | $27.0K | -4.46% | — | Stalk |
| Mar 2, 2026 | Sell | IOVA | Frederick G Vogt | Interim CEO & General Counsel | 22,809 | $3.79 | $3.9B | -8.12% | +388.64% | $86.4K | -3.34% | — | Stalk |
| Feb 24, 2026 | Sell | IOVA | Daniel Gordon Kirby | Chief Commercial Officer | 34,165 | $3.78 | $3.9B | -8.12% | +388.64% | $129.1K | -19.69% | — | Stalk |
| Feb 10, 2026 | Sell | IOVA | Daniel Gordon Kirby | Chief Commercial Officer | 16,450 | $2.60 | $3.9B | -8.12% | +388.64% | $42.8K | -10.97% | — | Stalk |
| Dec 1, 2025 | Sell | IOVA | Raj K. Puri | Chief Regulatory Officer | 2,467 | $2.23 | $3.9B | -8.12% | +388.64% | $5.5K | -1.00% | — | Stalk |
| Dec 1, 2025 | Sell | IOVA | Igor Bilinsky | Chief Operating Officer | 6,250 | $2.20 | $3.9B | -8.12% | +388.64% | $13.8K | -2.37% | — | Stalk |
| Dec 1, 2025 | Sell | IOVA | Finckenstein Friedrich Graf | Chief Medical Officer | 6,448 | $2.20 | $3.9B | -8.12% | +388.64% | $14.2K | -2.34% | — | Stalk |
| Dec 1, 2025 | Sell | IOVA | Frederick G Vogt | Interim CEO & General Counsel | 22,127 | $2.21 | $3.9B | -8.12% | +388.64% | $48.9K | -1.90% | — | Stalk |
| Sep 2, 2025 | Sell | IOVA | Raj K. Puri | Chief Regulatory Officer | 2,467 | $2.19 | $3.9B | -8.12% | +388.64% | $5.4K | -0.99% | — | Stalk |
| Sep 2, 2025 | Sell | IOVA | Igor Bilinsky | Chief Operating Officer | 6,250 | $2.19 | $3.9B | -8.12% | +388.64% | $13.7K | -3.77% | — | Stalk |
| Sep 2, 2025 | Sell | IOVA | Finckenstein Friedrich Graf | Chief Medical Officer | 6,448 | $2.19 | $3.9B | -8.12% | +388.64% | $14.1K | -3.74% | — | Stalk |
| Sep 2, 2025 | Sell | IOVA | Frederick G Vogt | Interim CEO & General Counsel | 22,127 | $2.19 | $3.9B | -8.12% | +388.64% | $48.5K | -3.04% | — | Stalk |
| Jun 5, 2025 | Buy | IOVA | Daniel Gordon Kirby | Chief Commercial Officer | 30,000 | $1.84 | $3.9B | -8.12% | +388.64% | $55.2K | — | — | Stalk |
| Jun 2, 2025 | Sell | IOVA | Raj K. Puri | Chief Regulatory Officer | 2,467 | $1.76 | $3.9B | -8.12% | +388.64% | $4.3K | -0.98% | — | Stalk |
| Jun 2, 2025 | Sell | IOVA | Jean-Marc Bellemin | Chief Financial Officer | 4,464 | $1.76 | $3.9B | -8.12% | +388.64% | $7.9K | -3.53% | — | Stalk |
| Jun 2, 2025 | Sell | IOVA | Igor Bilinsky | Chief Operating Officer | 6,250 | $1.76 | $3.9B | -8.12% | +388.64% | $11.0K | -3.63% | — | Stalk |
| Jun 2, 2025 | Sell | IOVA | Finckenstein Friedrich Graf | Chief Medical Officer | 6,448 | $1.76 | $3.9B | -8.12% | +388.64% | $11.3K | -3.61% | — | Stalk |
| Jun 2, 2025 | Sell | IOVA | Frederick G Vogt | Interim CEO & General Counsel | 22,127 | $1.76 | $3.9B | -8.12% | +388.64% | $38.9K | -2.95% | — | Stalk |
| May 23, 2025 | Buy | IOVA | Raj K. Puri | Chief Regulatory Officer | 5,600 | $1.74 | $3.9B | -8.12% | +388.64% | $9.7K | +2.78% | — | Stalk |
| May 14, 2025 | Buy | IOVA | Frederick G Vogt | Interim CEO & General Counsel | 25,000 | $1.69 | $3.9B | -8.12% | +388.64% | $42.3K | +7.15% | — | Stalk |
| Mar 14, 2025 | Sell | IOVA | Raj K. Puri | Chief Regulatory Officer | 2,509 | $3.59 | $3.9B | -8.12% | +388.64% | $9.0K | -1.23% | — | Stalk |
| Mar 3, 2025 | Sell | IOVA | Raj K. Puri | Chief Regulatory Officer | 19,984 | $4.04 | $3.9B | -8.12% | +388.64% | $80.7K | -7.71% | — | Stalk |
| Mar 3, 2025 | Sell | IOVA | Jean-Marc Bellemin | Chief Financial Officer | 31,734 | $4.04 | $3.9B | -8.12% | +388.64% | $128.2K | -20.05% | — | Stalk |
| Mar 3, 2025 | Sell | IOVA | Igor Bilinsky | Chief Operating Officer | 33,302 | $4.04 | $3.9B | -8.12% | +388.64% | $134.5K | -16.22% | — | Stalk |
| Mar 3, 2025 | Sell | IOVA | Finckenstein Friedrich Graf | Chief Medical Officer | 33,470 | $4.04 | $3.9B | -8.12% | +388.64% | $135.2K | -15.76% | — | Stalk |
| Mar 3, 2025 | Sell | IOVA | Frederick G Vogt | Interim CEO & General Counsel | 95,413 | $4.04 | $3.9B | -8.12% | +388.64% | $385.5K | -11.63% | — | Stalk |
| Jan 14, 2025 | Sell | IOVA | Igor Bilinsky | Chief Operating Officer | 1,578 | $5.89 | $3.9B | -8.12% | +388.64% | $9.3K | -2.61% | — | Stalk |
| Jan 14, 2025 | Sell | IOVA | Finckenstein Friedrich Graf | Chief Medical Officer | 1,578 | $5.89 | $3.9B | -8.12% | +388.64% | $9.3K | -2.41% | — | Stalk |
| Jan 14, 2025 | Sell | IOVA | Frederick G Vogt | Interim CEO & General Counsel | 9,955 | $5.89 | $3.9B | -8.12% | +388.64% | $58.6K | -4.31% | — | Stalk |
| Dec 16, 2024 | Sell | IOVA | Raj K. Puri | Chief Regulatory Officer | 3,759 | $7.84 | $3.9B | -8.12% | +388.64% | $29.5K | -2.24% | — | Stalk |
| Dec 2, 2024 | Sell | IOVA | Igor Bilinsky | Chief Operating Officer | 1,784 | $9.07 | $3.9B | -8.12% | +388.64% | $16.2K | -2.32% | — | Stalk |
| Dec 2, 2024 | Sell | IOVA | Finckenstein Friedrich Graf | Chief Medical Officer | 1,982 | $9.07 | $3.9B | -8.12% | +388.64% | $18.0K | -2.35% | — | Stalk |
| Dec 2, 2024 | Sell | IOVA | Frederick G Vogt | Interim CEO & General Counsel | 4,426 | $9.07 | $3.9B | -8.12% | +388.64% | $40.1K | -1.66% | — | Stalk |
| Oct 14, 2024 | Sell | IOVA | Igor Bilinsky | Chief Operating Officer | 1,428 | $9.77 | $3.9B | -8.12% | +388.64% | $14.0K | -2.38% | — | Stalk |
| Oct 14, 2024 | Sell | IOVA | Finckenstein Friedrich Graf | Chief Medical Officer | 1,428 | $9.77 | $3.9B | -8.12% | +388.64% | $14.0K | -2.20% | — | Stalk |
| Oct 14, 2024 | Sell | IOVA | Frederick G Vogt | Interim CEO & General Counsel | 8,851 | $9.77 | $3.9B | -8.12% | +388.64% | $86.5K | -3.78% | — | Stalk |
| Sep 3, 2024 | Sell | IOVA | Jean-Marc Bellemin | Chief Financial Officer | 11,891 | $10.85 | $3.9B | -8.12% | +388.64% | $129.0K | -18.39% | — | Stalk |
| Sep 3, 2024 | Sell | IOVA | Igor Bilinsky | Chief Operating Officer | 13,675 | $10.85 | $3.9B | -8.12% | +388.64% | $148.4K | -8.79% | — | Stalk |
| Sep 3, 2024 | Sell | IOVA | Finckenstein Friedrich Graf | Chief Medical Officer | 13,874 | $10.85 | $3.9B | -8.12% | +388.64% | $150.5K | -8.26% | — | Stalk |
| Sep 3, 2024 | Sell | IOVA | Frederick G Vogt | Interim CEO & General Counsel | 24,339 | $10.85 | $3.9B | -8.12% | +388.64% | $264.1K | -4.95% | — | Stalk |
| Jul 15, 2024 | Sell | IOVA | Igor Bilinsky | Chief Operating Officer | 1,428 | $8.68 | $3.9B | -8.12% | +388.64% | $12.4K | -2.96% | — | Stalk |
| Jul 15, 2024 | Sell | IOVA | Finckenstein Friedrich Graf | Chief Medical Officer | 1,428 | $8.68 | $3.9B | -8.12% | +388.64% | $12.4K | -2.70% | — | Stalk |
| Jul 15, 2024 | Sell | IOVA | Frederick G Vogt | Interim CEO & General Counsel | 8,851 | $8.68 | $3.9B | -8.12% | +388.64% | $76.8K | -4.22% | — | Stalk |
| Jun 3, 2024 | Sell | IOVA | Igor Bilinsky | Chief Operating Officer | 1,784 | $8.37 | $3.9B | -8.12% | +388.64% | $14.9K | -2.70% | — | Stalk |
| Jun 3, 2024 | Sell | IOVA | Finckenstein Friedrich Graf | Chief Medical Officer | 1,982 | $8.37 | $3.9B | -8.12% | +388.64% | $16.6K | -2.69% | — | Stalk |
| Jun 3, 2024 | Sell | IOVA | Frederick G Vogt | Interim CEO & General Counsel | 4,426 | $8.37 | $3.9B | -8.12% | +388.64% | $37.0K | -1.97% | — | Stalk |
| Apr 15, 2024 | Sell | IOVA | Igor Bilinsky | Chief Operating Officer | 1,427 | $11.89 | $3.9B | -8.12% | +388.64% | $17.0K | -2.98% | — | Stalk |
| Apr 15, 2024 | Sell | IOVA | Finckenstein Friedrich Graf | Chief Medical Officer | 1,427 | $11.89 | $3.9B | -8.12% | +388.64% | $17.0K | -2.72% | — | Stalk |
| Apr 15, 2024 | Sell | IOVA | Frederick G Vogt | Interim CEO & General Counsel | 8,851 | $11.89 | $3.9B | -8.12% | +388.64% | $105.2K | -4.16% | — | Stalk |
| Mar 4, 2024 | Sell | IOVA | Igor Bilinsky | Chief Operating Officer | 7,287 | $16.96 | $3.9B | -8.12% | +388.64% | $123.6K | -10.11% | — | Stalk |
| Mar 4, 2024 | Sell | IOVA | Finckenstein Friedrich Graf | Chief Medical Officer | 8,053 | $16.96 | $3.9B | -8.12% | +388.64% | $136.6K | -10.01% | — | Stalk |
| Mar 4, 2024 | Sell | IOVA | Frederick G Vogt | Interim CEO & General Counsel | 11,449 | $16.96 | $3.9B | -8.12% | +388.64% | $194.2K | -5.11% | — | Stalk |
| Jan 16, 2024 | Sell | IOVA | Igor Bilinsky | Chief Operating Officer | 1,577 | $8.37 | $3.9B | -8.12% | +388.64% | $13.2K | -3.69% | — | Stalk |
| Jan 16, 2024 | Sell | IOVA | Finckenstein Friedrich Graf | Chief Medical Officer | 1,577 | $8.37 | $3.9B | -8.12% | +388.64% | $13.2K | -3.40% | — | Stalk |
| Jan 16, 2024 | Sell | IOVA | Frederick G Vogt | Interim CEO & General Counsel | 6,530 | $8.37 | $3.9B | -8.12% | +388.64% | $54.7K | -3.45% | — | Stalk |
| Oct 16, 2023 | Sell | IOVA | Finckenstein Friedrich Graf | Chief Medical Officer | 1,395 | $3.57 | $3.9B | -8.12% | +388.64% | $5.0K | -2.92% | — | Stalk |
| Oct 16, 2023 | Sell | IOVA | Igor Bilinsky | Chief Operating Officer | 1,395 | $3.57 | $3.9B | -8.12% | +388.64% | $5.0K | -3.16% | — | Stalk |
| Oct 16, 2023 | Sell | IOVA | Frederick G Vogt | Interim CEO & General Counsel | 8,851 | $3.57 | $3.9B | -8.12% | +388.64% | $31.6K | -4.47% | — | Stalk |